Conference abstract · 27 Feb 2017
Short communicationPublished Oct 2021
Using plural phages to treat Multiple Drug Resistant (MDR) Acinetobacter baumannii
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Acinetobacter baumannii (AB) is one of the important multiple drug resistant (MDR) bacterial infection with environmental contamination especially in hospitals. AB is the major fatal cause of acquired hospital bacterial infection. With the limitation to develop new antibiotic drug, nowadays, phage therapy is reignited as an alternative strategy to fight against MDR bacterium. One of the main problems concerning phage therapy is that bacterium can develop to be a lysogen which becomes resistant to the same phage treatment. This lysogenic mechanism is regulated when bacterium host is infected by temperate phage which unfortunately seems to be the major kind of isolated phages by various researchers. It is seldom to isolate virulent phage which can keep re-infecting the bacterial host by the phage’s progeny without lysogenic pathway. Using the proper amounts of temperate phage, so called multiplicity of infection (MOI), to infect the bacterial hosts can theoretically prevent lysogenic pathway. However, it is not practical to perfectly prepare the proper amount of MOI for the treatment. In this study, many isolated ABs have been obtained from patients. The AB 116 and AB 160 are used as the models to study their susceptibility to phage therapy. Plural kinds of AB-phages (bacteriophages of AB) for each particular AB have also been isolated and called AB-phage a, b, c and d. AB-phage a and c can infect AB 116 while AB 160 can be infected by AB-phage a, b and d. In this presentation, using plural ABphage to treat AB in vitro will be presented and discussed.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
In-vivo efficacy of a bacteriophage cocktail for the control of multiple drug-resistant (MDR) Acinetobacter baumannii infection of lungs
Short communication · 5 Aug 2021
Distribution of multiple-drug resistant (MDR) tuberculosis among HIV sero-positive and sero- negative populations in Ilorin, North-Central Nigeria
Research article · 29 Feb 2016
Multiple drug resistance (MDR) and phenotypic detection of extended spectrum β-lactamases (ESBL) and metallo β-lactamases (MBL) producing enterobacteriaceae isolates of neonatal sepsis
Research article · 22 Feb 2016
In vitro evaluation of antibacterial potential of Andrographis paniculata against resistant bacterial pathogens methicillin resistant Staphylococcus aureus (MRSA) and multiple drug resistant Escherichia coli (MDR E. coli)
More from this journal
The newest in Journal of Pharmaceutical Sciences & Emerging Drugs.
Research article · 18 Feb 2025
Comparative Biowaiver Study of Moxifloxacin in Immediate Release of Oral Solid Dosage Form
Perspective · 23 Aug 2024
Drug Intoxication in Adolescents: Warning Signs and Prevention
Short communication · 20 Aug 2024
Bio-organic Chemistry Approaches to Modulating Protein- Ligand Interactions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Sciences & Emerging Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Tirasak Pasharawipas”

